TITLE

US follows Canadian lead

AUTHOR(S)
Chatelain, Nicole
PUB. DATE
February 2008
SOURCE
CMAJ: Canadian Medical Association Journal;2/26/2008, Vol. 178 Issue 5, p539
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on Health Canada's advanced consumer health advisory regarding children's cold medications. The consumer health advisory is issued by Health Canada on October 11, 2007. It states that infant's cold medications result to serious complications such as drug overdose and death. The advisory also leads to Health Canada's studies on the effects of over the counter medications on children aged 2-11. Health Canada together with United States Food and drug Administration also remind child caregivers to avoid giving cold or fever medication to two years old children.
ACCESSION #
29440424

 

Related Articles

  • The PPA Blues. Smith, Ian K. // Time International (South Pacific Edition);10/30/2000, Issue 43, p77 

    Reports on the health concerns surrounding the drug Phenylpropanolamine (PPA), a common ingredient in over-the-counter pharmaceuticals. Research that has been conducted on the product; Recommendation from the United States Food and Drug Administration that the drug be banned; What effect the...

  • The PPA Blues. Smith, Ian K. // Time;10/30/2000, Vol. 156 Issue 18, p101 

    Reports on the health concerns surrounding the drug Phenylpropanolamine (PPA), a common ingredient in over-the-counter pharmaceuticals. Research that has been conducted on the product; Recommendation from the United States Food and Drug Administration that the drug be banned; What effect the...

  • FDA Ready to Issue Sunscreen Regulations. Wynn, Paul // Dermatology Times;May99, Vol. 20 Issue 5, p24 

    Comments on the completion of regulations for over-the-counter sunscreen products by the United States Food and Drug Administration (FDA). Speculation as to why FDA took a long time in developing regulations; Safeness of zinc oxide as ingredient; Absence of guidelines on how to test products...

  • Tracking Washington.  // MondayMorning;3/12/2012, Vol. 20 Issue 11, p1 

    The article reports on the U.S. Food and Drug Administration's (FDA) plan regarding the over-the-counter availability of prescription drugs that are used in the treatment of common chronic diseases like cholesterol and diabetes. It informs that the main goal of the FDA's plan is to make the...

  • FDA taking closer look at OTC antiseptics. COONS, REBECCA // Chemical Week;5/4/2015, Vol. 177 Issue 13, p12 

    The article reports on a proposed rule issued by the U.S. Food and Drug Administration that requests for additional scientific data on the safety and effectiveness of over-the-counter health-care antiseptics.

  • Is a third class of drugs on the way?  // Medical Economics;4/8/2005, Vol. 82 Issue 7, p17 

    Discusses the reason of the U.S. Food and Drug Administration for not allowing the over the counter purchase of Mevacor. Indication for the treatment of the medication; Argument of pharmacists and pharmacy trade association regarding drug prescription and buying of certain drugs; Suggestion on...

  • Child Health ALERT. Mitchell, Allen A. // Pediatrics for Parents;Nov/Dec2010, Vol. 26 Issue 11/12, p20 

    The article looks at the effectiveness of dosing devices and instructions on oral liquid over-the-counter (OTC) medications. Based on the study led by Dr. H. Shonna Yin, it is revealed that before the U.S. Food and Drug Administration issued guidelines on OTC products, dosing devices and...

  • USE ACETAMINOPHEN WITH CAUTION.  // Body Bulletin;Sep2003, Vol. 4 Issue 9, p1 

    The U.S. Food and Drug Administration has advised that one should not take more than the recommended dose and should never use more than one acetaminophen-containing product in the same day. An overdose can cause acute liver failure and even death. Acetaminophen is an effective pain reliever...

  • Sunscreen following PDT; OTC hydroquinone.  // Dermatology Times;May2007, Vol. 28 Issue 5, p64 

    The article presents questions and answers related to dermatology. One question focuses on what best sunscreen can used following photodynamic therapy. Another question was raised on why the U.S. Food and Drug Administration (FDA) has proposed the removal of hydroquinone from the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics